Incident Data: Filling the Gaps, Identifying the Value, and Prioritizing Needed Information. Pat Baird October 6 th, 2010
|
|
- Calvin Garrett
- 6 years ago
- Views:
Transcription
1 Incident Data: Filling the Gaps, Identifying the Value, and Prioritizing Needed Information Pat Baird October 6 th, 2010
2 Goal: Look for patterns in the public data to know where to dig for additional investigation Goal is not to repackage or assess any single complaint instead, look for commonalities Meet this by: Look at relative (not absolute) numbers Look for contributors to Harm Look for which safety system failed 2
3 Presentation Overview Methodology Literature Review Analysis Results by Device Type Recall Review Results Summary Open Discussion 3
4 Presentation Overview Detailed Methodology Approach Types of Data Collected Problems Encountered Literature Review Analysis Results by Device Type Recall Review Results Summary Open Discussion 4
5 Review Approach Look for broad patterns of harm Use public data sources Literature / Conference Proceedings Manufacturer and User Facility Device Experience (MAUDE) FDA Class I Recall list 5
6 Review Approach Recalls & Lit Literature / Conference Proceedings Examined 10 years of papers regarding the causes of Harm, but not papers of recommended solutions FDA Class I Recall list Examined 5+ years of Class I recalls for infusion devices 6
7 Review Approach MAUDE Manufacturer and User Facility Device Experience (MAUDE) 3 year review: 1/1/ /31/2009 All Product Types in Guidance except Insulin All manufacturers Death & Injury only, excluded malfunctions 7
8 Data Collected Asking the 5Ws + H Who Age Adult, Child What Outcome Death, Injury When Phase Setup, Programming, Running, Handoff, Teardown Where Care Area ICU, L&D, Home Drug Family Vasoactive, TPN, Insulin... Where (contd) Device Type Syringe, Ambulatory, LVP, PCA Device Configuration Single, Multiple channel device How Hazardous Situation Over Infusion, Under Infusion, Free Flow, Interruption Why Cause Failure, Use Error, Amount/Concentration Slip... 8
9 Additional Data Collected Was there a drug library limits warning noted? Was there a 2 nd clinician verification step noted? Was the device evaluated? Was the device s internal log reviewed? 9
10 Sidebar: Measurement System Analysis & MAUDE Reporting There is variation any time you go to measure something. How repeatable and reliable do I need my measurement system to be? Is MAUDE an acceptable measuring tool? What are the alternatives? 10
11 EVENT DESCRIPTION The customer contact reported an adverse event while the device was in use. On an unspecified date and time, the device was programmed to deliver an unspecified pain medication via an intrathecal catheter and the delivery was started. No specific programming parameters were provided. After an unspecified length of time, the nurse found the patient "face down in bed unresponsive" and a code was initiated. The device was removed from clinical service. During testing at the user facility, the customer contact reported the device passed testing. Multiple unsuccessful attempts were made for additional event information. If additional information is obtained, a follow up report will be submitted. 11
12 Complicating Factors MAUDE is a self report system, records might not contain all necessary information Misclassification 15% of reports about PCA devices were found in General Purpose MAUDE only covers device related issues issues with misconnections, pharmacy errors, drug interaction, etc., will not show up 12
13 Presentation Overview Detailed Methodology Literature Review Analysis Results by Device Type Recall Review Results Summary Open Discussion 13
14 Literature Review Challenges Case reports are about specific incidents, not broad categories Conference proceedings often made best practice recommendations but those are solutions for unstated problems. 14
15 Patient Safety Issues With Patient Controlled Analgesia [D Arcy] A hospital s review of 56 PCA related events showed the sources of error as: PCA programming 71% Human factors / wrong meds: 15% Equipment problems 9% Ordering errors 5% 15
16 Patient Safety Issues With Patient Controlled Analgesia [D Arcy] cont d Common programming errors include: Confusion over milligrams and milliliters PCA bolus dose being confused with the basal rate Loading dose programmed as a bolus dose Wrong lockout selected Wrong medication concentration entered 16
17 Parenteral Medication Errors [Santell] Presented at the 2008 ASHP IV Safety Summit. A review of the MEDMARX database for parenteral errors. 126,596 parenteral errors 3,873 harmful parenteral errors 25 fatalities 17
18 P.M.E. Top 10 Locations of Harmful Parenteral Errors Category MEDMARX % Running % Nursing Unit 49% 49% ICU 14% 63% Pharmacy 9% 72% ED 7% 79% Surgical Services 5% 84% Radiology 3% 88% Maternity/LD 2% 90% Oncology 2% 92% Long term care 1% 93% Outpatient Clinics 1% 94% 18
19 P.M.E. Top Therapeutic Categories most often Involved with Harmful Parenteral Errors Category MEDMARX % Running % Insulin 18% 18% Opiod Analgesics 17% 35% Blood Coagulation Modifiers 9% 44% Beta Lactam Antimicrobials 6% 50% Electrolytes/Minerals 4% 54% Anti Infectives(other) 3% 57% Sedatives/Hypnotics/Anxiolytics 3% 61% Autonomic Medications 3% 64% Adrenal Corticosteriods 2% 66% Diuretics 2% 68% 19
20 Parenteral Med Errors Top Errors Category MEDMARX % Running % Improper Dose/quantity 31% 31% Omission 24% 55% Unauthorized/wrong drug 12% 67% 20
21 Adverse Events with Medical Devices in Anesthesia and Intensive Care Unit Patients Recorded in the French Safety Database in [Beydon] Reviewed 4,188 records in French AFSSAPS Database; 138 Severe Events involving infusion devices Nature of Problem % of Severe Events Error in infusion rate 24% Disconnection and migration in vascular bed 13% Significant vessel lesion during insertion 9% Unrecognized leaks with bleeding 7% 21
22 Presentation Overview Detailed Methodology Literature Review Analysis Results by Device Type MAUDE Review Metrics 5 Ws + H for each Device Type Recall Review Results Summary Open Discussion 22
23 Takeaways from MAUDE Review In general: 1. Rarely was there any Who 2. Quality of report varied by device type 3. Death reports had minimal information; Injury reports had much more 4. FRN (General Purpose) devices had the most complete reporting 23
24 3 yr Review Metrics by Device Type Product Type # D & I Reports # Unique D & I # Injuries # D & PD PCA (MEA) Elastomeric (MEB) Enteral (LZH) General Purpose (FRN) 347* Insulin Body Worn (OPP) Insulin (LZG) Not Reviewed Pump Accessory (MRZ) Total
25 PCA MAUDE Data Review Report Date 1/1/ /31/2009 Event Date 1/1/ /31/2009 Product Code = MEA Death & Injury Reports All Manufacturers / All Brands 160 D&I Reports / 128 Events Meet Criteria
26 PCA What happened? Denominator: 128 Adverse Events Death & Possible Death 13% Injury 87% 26
27 PCA When did it happen? Running 4% Global 7% Change 8% Programming Pump 34% Unknown 47% 27
28 PCA How did it happen? Over Infusion 71% Free Flow 5% Other 1% Unknown 23% 28
29 PCA Why did it happen? Other 3% Unknown 42% Use Error 55% 29
30 Why Use Error Detail # Type of Error % 1 Right data, wrong field a. Drug/Dose Slip 32% 5 6 1a b. Volume/Concentration 3% c. Rate / Concentration Slip 4% 2 Decimal Point Error 10% 3 Wrong Unit ( ml vs mg ) 7% 4 Manipulation Bolus 14% 5 Mis programming 23% 6 Other Use Error 7% b 1c 30
31 Swiss Cheese Theory of Organizational Vulnerability [James Reason] Graphics taken from: The Human Factors Analysis and Classification System HFACS The Swiss cheese model of accident causation February 2000 Scott A. Shappell FAA Civil Aeromedical Institute Oklahoma City, OK Douglas A. Wiegmann University of Illinois at Urbana Champaign Institute of Aviation Savoy, IL
32 Why Use Error Detail # Type of Error % 1 Right data, wrong field a. Drug/Dose Slip 32% 5 6 1a b. Volume/Concentration 3% c. Rate / Concentration Slip 4% 2 Decimal Point Error 10% 3 Wrong Unit ( ml vs mg ) 7% 4 Manipulation Bolus 14% 5 Mis programming 23% 6 Other Use Error 7% b 1c 32
33 PCA 3 Yr. Summary What (Outcome) Injury 112 Death 16 When (Phase) Unknown 60 Programming Pump 44 Change 10 Global 19 Infusion Running 5 Where How (Hazardous Situation) Unknown 30 Over infusion 91 Free Flow 6 Other 1 Why (Cause ) Wrong Field Decimal Point Error 7 13 Wrong units selected 5 9 Manipulation Bolus Mis programming Other Use Error
34 PCA Additional Information After the Adverse Event 49 of 128 Device Log Examined (38%) 28 of 128 Devices Evaluated (22%) When Use Error was a Cause.. 5 of 67 were not caught by Second Clinician Verification (7%) 11 of 67 continued despite a Limits Warning (16%) 34
35 Elastomeric MAUDE Data Review Report Date 1/1/ /31/2009 Event Date 1/1/ /31/2009 Product Code = MEB Death & Injury Reports All Manufacturers / All Brands 498 D&I Reports / 189 Events Meet Criteria
36 Elastomeric What happened? Injury 98% Denominator: 189 Adverse Events Death & Possible Death 2% 36
37 Elastomeric When did it happen? Unknown 62% Teardown 14% Infusion Running 14% Global 9% Other 1% 37
38 Elastomeric How did it happen? Bodily Injury 56% Foreign Object 14% Infection 9% Over Infusion 5% Unknown 5% Other 4% Under Infusion 3% Interruption 1% Chemical Exp 1% Allergic Reaction 1% 38
39 Elastomeric Why did it happen? Catheter Damage 14% Joint / Chondrolysis 53% Use Error 2% Leak 2% Other 5% Unknown 24% 39
40 Elastomeric 3 Yr. Summary What (Outcome) Injury 185 Death 4 When (Phase) Unknown 118 Tear Down 27 Infusion Running 26 Global 17 Setup 1 Where How (Hazardous Situation) Bodily Injury 105 Foreign Object 27 Infection 17 Over Infusion 10 Other 30 Why (Cause) Joint / Chondrolysis Catheter Damage Leak
41 Enteral MAUDE Data Review Report Date 1/1/ /31/2009 Event Date 1/1/ /31/2009 Product Code = LZH Death & Injury Reports All Manufacturers / All Brands 58 D&I Reports / 40 Events Meet Criteria
42 Harm when using an Enteral pump? EVENT DESCRIPTION It was reported to [redacted] that a customer had an issue with a feeding pump. The customer reported that the pump was set at 35ml/hr and the feeding bag was full (at 500ml). At 6am the next morning, she found her daughter unresponsive/deceased and the bag completely empty. 42
43 Enteral What happened? Injury 92% Denominator: 40 Adverse Events Death & Possible Death 8% 43
44 Enteral When did it happen? Manage Exceptions 35% Infusion Running 15% Unknown 37% Global 5% Programming Pump 8% 44
45 Enteral How did it happen? Under Infusion 18% Over Infusion 17% Gastric Air Delivery 17% Interruption 22% Other 5% Exposure to Electrical Energy 3% Burn/Fire/Smoke 3% Unknown 17% 45
46 Enteral Why did it happen? Other 10% Use Error 10% Unknown 47% Failed to Alarm 33% 46
47 Enteral 3 Yr. Summary What (Outcome) Injury 37 Death 3 When (Phase) Unknown 15 Manage Exceptions 14 Infusion Running 6 Programming Pump 3 Global 2 Where How (Hazardous Situation) Unknown 7 Interruption 9 Over Infusion 7 Under Infusion 7 Gastric Air Delivery 6 Other 4 Why (Cause) Failed to Alarm Use Error 4 8 Other
48 Enteral Additional Information After the Adverse Events, 9 of 40 devices were evaluated (23%) 12 of 40 events were reported as being on a child (30%) 48
49 General Purpose (FRN) MAUDE Data Review Report Dates 1/1/ /31/2009 Subset Event Dates 1/1/ /31/2009 Subset Product Code = FRN Death & Injury Reports All Manufacturers / All Brands 600 D&I Reports / 347 Reviewed / 238 Events Meet Criteria
50 FRN What happened? Injury 76% Death & Possible Death 24% Denominator: 238 Adverse Events 50
51 FRN When did it happen? Programming 21% Infusion Running 41% Unknown 25% Change 6% Setup 3% Global 1% Deployment 1% Hand off 1% Tear Down 1% 51
52 FRN How did it happen? Under Infusion 4% Over Infusion 50% Interruption 29% Free Flow 12% Delay 1% Exposure to Electrical Energy 1% Unknown 3% 52
53 FRN Why did it happen? Secondary Use Error 3% Use Error 33% Unknown 27% Alarm 3% Failure/ Malfunction 22% Failed to Alarm 5% Physical Damage 6% Other 1% 53
54 Why Use Error Detail Decimal Point Error 30% Misprogramming 53% Wrong Units Selected 7% Drug/Dose Slip 7% Rate/Concentration Slip 3% 54
55 General Purpose 3 Yr. Summary What (Outcome) Injury 181 Death 57 When (Phase) Unknown 60 Infusion Running 98 Programming Pump 50 Change 14 Setup 7 Other 9 How (Hazardous Situation) Unknown 8 Over Infusion 118 Under Infusion 10 Interruption 70 Free Flow 28 Why (Cause) Use Error Secondary Use Error 7 10 Alarm 8 11 Failure / Malfunction Failed to Alarm Physical Damage
56 General Purpose Addt l Information After the Adverse Event 63 of 238 Device Log Examined (26%) 77 of 238 Devices Evaluated (32%) Breakdown of device type LVP 187 Ambulatory 26 Syringe Pump 26 56
57 Presentation Overview Detailed Methodology Literature Review Analysis Results by Device Type Recall Review Results Summary Open Discussion 57
58 Recall Review Timeframe: 1/1/2005 through 9/30/2010 Infusion pumps excluding Insulin Class I Recalls All manufacturers / all brands 12 Recalls / 21 Issues 58
59 Class I Recall Review Issue Count % Failure Leads to Interruption 8 38% Use Related Error 5 24% Failure Leads to Other Hazard 4 19% Fail to Alarm 2 10% False Alarm 1 5% Other 1 5% Total % 59
60 Presentation Overview Detailed Methodology Literature Review Analysis Results by Device Type Recall Review Results Summary Open Discussion 60
61 61
62 Elastomeric Harm per year Joint / Chondrolysis Catheter Damage Leak Use Error
63 PCA Enteral FRN Total Harm per year (42.6) (13.3) (79.3) (135.3) Failure / Malfunction Use: Mis programming Use: Drug / Dose Slip Use: Decimal Point Error Failed to Alarm Physical Damage Use: Manipulation Use: Wrong units Use: Other Alarm Use: Secondary Use: Rate / Conc. Slip Use: Volume / Conc. Slip Total
64 Presentation Overview Detailed Methodology Literature Review Analysis Results by Device Type Recall Review Results Summary Open Discussion 64
Important Information about your 2.0 ml Animas Insulin Pump Cartridges
URGENT: INSULIN PUMP 2.0 ml CARTRIDGE RECALL February 24, 2011 Dear Animas Pumper: Important Information about your 2.0 ml Animas Insulin Pump Cartridges Animas Corporation is dedicated to supporting pumpers
More informationMulti-Therapy Smart Infusion for Home Care
Multi-Therapy Smart Infusion for Home Care 1,200 ml 7:16 AM Dosing 7:13 AM 265 ml 7:15 AM Intermittent 500 ml 7:14 AM Dosing Current rate is 36 ml/hr Reservoir volume empty in 96 Hrs 0 Min Dose complete
More informationMultiple IV Infusions: Research and Recommendations National Coalition for Infusion Therapy Safety Mar 12, 2015
Multiple IV Infusions: Research and Recommendations National Coalition for Infusion Therapy Safety Mar 12, 2015 Mark Fan Sonia Pinkney Andrea Cassano-Piché Overview Introduction Research findings and recommendations
More information1. Continuous Glucose Monitoring
1. Continuous Glucose Monitoring 1. Physiology of interstitial fluid glucose 2. Comparison of CGM and self-monitored blood glucose (SMBG) data 3. Insulin dosing indication in BGM vs. CGM & the FDA 4. Protection
More informationPatient Harm with Opioids: Can We Truly Reduce the Risk? Ali-Reza Shah-Mohammadi, PharmD, MS, FISMP
Patient Harm with Opioids: Can We Truly Reduce the Risk? Ali-Reza Shah-Mohammadi, PharmD, MS, FISMP Clinical Pharmacy Specialist Medication Safety Pharmacy Medication Management & Analytics The University
More informationATI Skills Modules Checklist for Central Venous Access Devices
For faculty use only Educator s name Score Date ATI Skills Modules Checklist for Central Venous Access Devices Student s name Date Verify order Patient record Assess for procedure need Identify, gather,
More informationNEW! CADD -Solis Pain Management System with Programmed Intermittent Bolus (PIB) Your solution to better pain management for labor analgesia
NEW! CADD -Solis Pain Management System with Programmed Intermittent Bolus (PIB) Your solution to better pain management for labor analgesia To provide enough pain relief for childbirth labor and delivery
More informationVeterinary Infusion Solutions
Veterinary Infusion Solutions Caesarea Medical Electronics Vet Pro VIP 2000 Innovative Technology Simplified for Animals The Vet-Pro VIP 2000 is the golden standard amongst veterinary practitioners. Providing
More informationInnovative Approaches and New Technology to Gain Access
Innovative Approaches and New Technology to Gain Access The following is intended only for presentation to the Reimbursement and Access 2017 audience, August 17, 2017. This information is not for promotional
More informationRisk Management in Parenteral Nutrition. J. Boullata
Risk Management in Parenteral Nutrition J. Boullata Objectives Upon completion of this session, the participant will be able to: Describe safety issues with parenteral nutrition (PN) Present the PN-use
More informationNEW! CADD -Solis Pain Management System with Programmed Intermittent Bolus (PIB) Your solution to better pain management for labour analgesia
NEW! CADD -Solis Pain Management System with Programmed Intermittent Bolus (PIB) Your solution to better pain management for labour analgesia Programmed Intermittent Bolus (PIB) An innovative technique
More informationNEW! CADD -Solis Ambulatory Pain Management System with Programmed Intermittent Bolus (PIB)
NEW! CADD -Solis Ambulatory Pain Management System with Programmed Intermittent Bolus (PIB) Your solution to better pain management for post-operative pain Programmed Intermittent Bolus (PIB) An innovative
More informationINTRAVENOUS (IV) THERAPY AND VEIN ACCESS: GLOBAL MARKETS
INTRAVENOUS (IV) THERAPY AND VEIN ACCESS: GLOBAL MARKETS HLC046C November 2014 Mary C. Patton Project Analyst ISBN: 1-56965-982-6 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215
More informationISMP QuarterlyActionAgenda
One of the most important ways to prevent medication errors is to learn about problems that have occurred in other organizations and to use that information to prevent similar problems at your practice
More informationEvaluation of McKinley T34 Syringe Pumps
Evaluation of McKinley T34 Syringe Pumps Health Board Area Establishment Department Date of Evaluation Signature of Evaluator 1 No Statement Evidence Not All clinical areas have access to Access will be
More informationAmbu ACTion Pain Pumps
Ambu ACTion Pain Pumps ACTion Block Pain Pump The Ambu ACTion Block Pump is a disposable pain pump designed to give consistent, customized and non-narcotic pain therapy through a continuous peripheral
More informationMedtronic MiniMed Insulin Infusion Pumps
Medtronic MiniMed Insulin Infusion Pumps Patients should always discuss potential risks and benefits with a physician. Please review the product manual prior to use for detailed instructions and disclosure.
More informationIntravenous Fluid and Drug Therapy
11 Intravenous Fluid and Drug Therapy OUTLINE Overview Direct Intravenous Injections Continuous Intravenous Injections Solution Additives Calculating IV Components as Percentages Calculating IV Flow Rates
More informationChapter 64 Administration of Injectable Medications
Chapter 64 Administration of Injectable Medications Injectable Medications Injection or intravenous (IV) infusion More invasive than administration by mouth, rectum, or through the skin Common methods
More informationInnovation in motion BodyGuard ColorVision
Innovation in motion BodyGuard ColorVision Multi therapy solutions Offering greater flexibility through multiple applications at hospital or home. When managing multiple treatments, and looking for more
More informationStaying safe on an insulin pump
Staying safe on an insulin pump Exceptional healthcare, personally delivered Insulin pump therapy is a safe and effective way of treating diabetes. However due to the way the insulin is delivered, problems
More informationBetter Post-Op Pain Control Starts Here
Better Post-Op Pain Control Starts Here POST-OP PAIN CONTROL PUMP It s Easy to Get Started About the ACCUFUSER Pump Thank you for considering the This brochure makes it easy for For complete information
More informationMEDICAL MANAGEMENT POLICY
PAGE: 1of 8 This Medical policy is not a guarantee of benefits or coverage, nor should it be deemed as medical advice. In the event of any conflict concerning benefit coverage, the employer/member summary
More informationBeyond The Lockout Time. Kelcy Freeman, PharmD, BCPS April 20, 2017 REMEDI Pump Collaborative Spring Conference Chicago, IL
Beyond The Lockout Time Kelcy Freeman, PharmD, BCPS April 20, 2017 REMEDI Pump Collaborative Spring Conference Chicago, IL Disclosure I am a full-time employee of Smiths Medical, global provider of medical
More informationICD-9-CM Diagnosis Code options
ICD-9-CM Diagnosis Code options Diagnosis codes are used by both physicians and facilities to document the indication for the procedure. Intrathecal drug delivery is directed at managing chronic, intractable
More informationReport Reference Guide
Report Reference Guide How to use this guide Each type of CareLink report and its components are described in the following sections. Report data used to generate the sample reports was from sample patient
More informationCENTRAL IOWA HEALTHCARE Marshalltown, Iowa
CENTRAL IOWA HEALTHCARE Marshalltown, Iowa CARE OF PATIENT POLICY & PROCEDURES Policy Number: 4.84 Subject: Policy: Purpose: Continuous Epidural Analgesia Acute or chronic pain relief provided to a patient
More informationSafe Use of Opioids in Hospitals: Addressing The Joint Commission Sentinel Event Alert
Safe Use of Opioids in Hospitals: Addressing The Joint Commission Sentinel Event Alert Physician-Patient Alliance for Health & Safety (PPAHS) www.ppahs.org Panelists Michael Wong, JD - Physician-Patient
More informationReducing Intermittent Infusion Syringe Pump Errors via Weight-Based Safety Parameters
Reducing Intermittent Infusion Syringe Pump Errors via Weight-Based Safety Parameters Alison Bloomquist and Laura Seiberlich Abstract Historically, smart infusion pumps with dose error reduction software
More informationInfusion device incidents Lessons learned and recommendations
HA Convention 8 th May 2007 Infusion device incidents Lessons learned and recommendations Jason Ng, Andy Chung, Bonnie Wong, Becky PY Ho, Kate Choi, Anne Kwan, Joseph Lui, Fred Chan, Ella Ma, David Lau,
More informationSARASOTA MEMORIAL HOSPITAL NURSING PROCEDURE
SARASOTA MEMORIAL HOSPITAL NURSING PROCEDURE TITLE: ISSUED FOR: ADMINISTRATION OF A FEEDING (CONTINUOUS OR INTERMITTENT) OR MEDICATION VIA A GASTROSTOMY TUBE-ADULT Nursing DATE: REVIEWED: PAGES: 07/82
More informationVAN WERT COUNTY HOSPITAL. Policy/Procedure: Departmental No.: N 11-36A. Issue Date: 7-97 By: Nursing No. of Pages: 6
VAN WERT COUNTY HOSPITAL Policy/Procedure: Departmental No.: N 11-36A Issue Date: 7-97 By: Nursing No. of Pages: 6 Reviewed: 9-14, 8-11, 8-10 Revised: 9-14 Distribution List: All Nursing Departments Concurrence:
More informationJames Paul MD MSc FRCPC
SCIENCE VIGILANCE COMPASSION VIGILANCE Study: VItal sign monitoring with continuous pulse oximetry And wireless clinician notification after surgery James Paul MD MSc FRCPC Outline Background Rationale
More informationPump Basics for the School Nurse. Children's Endocrinology Center of Dallas
Pump Basics for the School Nurse Children's Endocrinology Center of Dallas Pump Basics Covers: A general overview of the insulin pump Refer to the manufacturer s website for the specific features of each
More informationSpecial Situations 1
Special Situations 1 Outline Continuous Nutrition Tube feeds TPN Steroids Pumps Perioperative BG Control 2 Patient receiving continuous TF or TPN Continuous nutrition coverage options: Analog q4hr Regular
More informationImproving Patient Safety and Compliance
Improving Patient Safety and Compliance Module 4 Includes Recommended Procedures Table of Contents Section A... 1 A.1 Intrathecal (IT) Doses... 1 Section B... 1 B.1 Vinca Alkaloids... 1 Section C... 2
More informationINSPIRED BY GIVE HER MORE. The MiniMed 670G system is the world s first insulin delivery system that automatically adapts to your child s needs.
INSPIRED BY GIVE HER MORE. The MiniMed 670G system is the world s first insulin delivery system that automatically adapts to your child s needs. * NOW APPROVED FOR AGES 7 AND UP. MORE TIME HERE TO USING
More informationWITH APPLICATIONS TO : ; : GENERAL AND SPECIALTY AREAS
f Fourth Edition WITH APPLICATIONS TO : ; : GENERAL AND SPECIALTY AREAS Joyce LeFever Kee, RN, MS Associate Professor Emerita College of Health and Nursing Sciences University of Delaware Newark, Delaware
More informationAviva Combo BLOOD GLUCOSE METER. Advanced Owner s Booklet for Self-Testing Only
Aviva Combo BLOOD GLUCOSE METER Advanced Owner s Booklet for Self-Testing Only Before You Start Testing About the meter and test strips Carefully read and follow the instructions in the Getting Started
More informationUrgent Notice September 16, 2014
Urgent Notice September 16, 2014 Voluntary Recall Notification: EDS 3 CSF External Drainage System PLEASE DISTRIBUTE THIS INFORMATION TO CLINICIANS WHO USE THIS DEVICE Dear OR Manager, Materials Manager,
More informationFeeding Protocols Enteral or Parenteral. AM Poleÿ 2012
Practical aspects on Feeding Protocols Enteral or Parenteral AM Poleÿ 2012 Enteral Feeding Facts A reduction in mortality Prophylaxis for stress ulcers Full-strength Time to start enteral nutrition If
More informationWho has responsibility for emerging technologies in diabetes management
ROYAL CHILDREN S HOSPITAL ACADEMIC CENTRE Who has responsibility for emerging technologies in diabetes management A/Prof Bernadette Richards, Adelaide Law School, University of Adelaide Prof Fergus Cameron,
More informationCATHETER ACCESS KIT. For use with Prometra Programmable Infusion Systems
CATHETER ACCESS KIT Caution: Federal (USA) Law restricts this device to sale by or on the order of a physician. Table of Contents Contents... 3 Description... 3 Indications... 3 Contraindications... 3
More informationUNDERSTANDING THE BASIC FEATURES AND MANAGEMENT IN THE SCHOOL SETTING CHRISTINE HERTLER RN BSN CDE & MARY MCCARTHY RN CDE
UNDERSTANDING THE BASIC FEATURES AND MANAGEMENT IN THE SCHOOL SETTING CHRISTINE HERTLER RN BSN CDE & MARY MCCARTHY RN CDE The insulin pump Replaces injections Delivers insulin through a soft cannula
More informationGLOOKO REPORT REFERENCE GUIDE
GLOOKO REPORT REFERENCE GUIDE November 2018 Version IFU-0010 02 Contents Intended Use... 2 Warnings... 2 Introduction... 3 Reports... 4 Report Criteria...4 Date Range... 4 Glucose Data Source... 4 Exercise
More informationFDA Perspective - Public Health Notification: Potentially Fatal Errors with GDH-PQQ Glucose Monitoring Technology Courtney C. Harper, Ph.D.
FDA Perspective - Public Health Notification: Potentially Fatal Errors with GDH-PQQ Glucose Monitoring Technology Courtney C. Harper, Ph.D., Director, Division of Chemistry and Toxicology Devices Office
More informationNeuroform Microdelivery Stent System
Neuroform Microdelivery Stent System Patient Information Booklet TABLE OF CONTENTS What is the Purpose of This Booklet?...2 What is a Wide Neck, Intracranial Aneurysm?...2 What is the Treatment for Wide
More informationCHEMOTHERAPY NETWORK GROUP POLICY FOR ADMINISTRATION OF CYTOTOXIC CHEMOTHERAPY
CHEMOTHERAPY NETWORK GROUP POLICY FOR ADMINISTRATION OF CYTOTOXIC CHEMOTHERAPY Version 4.0 March 2016 Review date March 2018 Introduction It is the purpose of this policy to provide clear guidelines that
More informationISMP 2017 Updates Best Practices for Hospital Pharmacists
ISMP 2017 Updates Best Practices for Hospital Pharmacists Lamis R. Karaoui, PharmD, BCPS Clinical Associate Professor Director of Experiential Education Lebanese American University School of Pharmacy
More informationP900 enteral syringepump
medicina P900 enteral syringe pump 1 medicina P900 enteral syringe pump P900 enteral syringepump The P900 enteral syringe pump has been designed to deliver small volumes of enteral feed, accurately and
More informationMri with baclofen pump
Mri with baclofen pump 830 South Main St Suite 2 Orrville, OH 44667. 1207 W. State St. Suite N Alliance, OH 44601. NeuroCare Orrville Hours: W & TH 7AM-4:30PM (subject to change). var r = [99, 104, 101,
More informationInsulin Pump Therapy. WakeMed Children s Endocrinology & Diabetes WakeMed Health & Hospitals Version 1.3, rev 5/21/13 MP
Insulin Pump Therapy WakeMed Children s Endocrinology & Diabetes Overview What is an insulin pump? What are the advantages and disadvantages of an insulin pump? Lifestyle Changes Food Management Exercise
More informationThe Drug Shortage Crisis
Objectives: The Drug Shortage Crisis Jay M. Mirtallo, MS, RPh, BCNSP, FASHP Director, MS in Health System Pharmacy Associate Professor of Clinical Pharmacy The Ohio State University, College of Pharmacy
More informationNeoConnect is the ideal ENFit product portfolio for use in all care environments. Pharmacy Adult ICUs PICU/NICU Home Care Alternate Care
NeoConnect is the ideal ENFit product portfolio for use in all care environments Pharmacy Adult ICUs PICU/NICU Home Care Alternate Care What do ENFit compliant NeoConnect syringes and accessories deliver
More informationEnsuring Safety of Anticoagulation Therapy
Ensuring Safety of Anticoagulation Therapy Abha Agrawal, MD, FACP Chief Medical Officer Kings County Hospital Clinical Associate Dean SUNY Downstate College of Medicine Brooklyn, NY NYACP Webinar April
More informationMEDICAL POLICY No R10 INFUSION SERVICES & EQUIPMENT
INFUSION SERVICES & EQUIPMENT Effective Date: August 1, 2017 Review Dates: 10/95, 12/99, 12/01, 11/02, 11/03, 11/04, 10/05, 10/06, 10/07, 10/08, 10/09, 4/10, 4/11, 4/12, 4/13, 5/14, 5/15, 2/16, 2/17, 5/17
More informationPAEDIATRIC NERVE BLOCK / WOUND INFILTRATION
PAEDIATRIC NERVE BLOCK / WOUND INFILTRATION Addendum to the MULTIDISCIPLINARY GUIDELINES FOR ACUTE PAIN MANAGEMENT IN CHILDREN AND YOUNG PEOPLE Policy Owner: Approved by: Ratified by: ABMU HB Pain Management
More information#NPPG2016. ENFit syringes. Andrew Wignell, Paediatric Pharmacist, Nottingham University Hospitals
#NPPG2016 ENFit syringes Andrew Wignell, Paediatric Pharmacist, Nottingham University Hospitals ENFit Syringes Andrew Wignell andrew.wignell@nuh.nhs.uk Objectives Describe the background to the changes
More informationWithin the proportion the two outside numbers are referred to as the extremes. The two inside numbers are referred to as the means.
Basic Formulas Speaker: Jana Ogden This lecture will demonstrate the expectations for performing a variety of the more complex calculations. You are expected to refer to your text and complete the designated
More informationINSPIRED BY GIVE HIM MORE. The MiniMed 670G system is the world s first insulin delivery system that automatically adapts to your child s needs.
INSPIRED BY GIVE HIM MORE. The MiniMed 670G system is the world s first insulin delivery system that automatically adapts to your child s needs. * NOW APPROVED FOR AGES 7 AND UP. Waterproof to a depth
More informationINTRODUCING. Potential Monotherapy Option 5 Provided in Convenient Vials 1 Reimbursable J-Code Available 3
INTRODUCING The only FDA-approved morphine sulfate for intrathecal and epidural pain management for use in continuous microinfusion devices, packaged in convenient, easy-to-use vials. Available, Agreed-Upon
More informationLearning Objectives. We will look at: pumps infusion sets injection sites programming/testing
Pump Mishaps Learning Objectives This session will provide you with some helpful solutions for correcting potential troubleshooting issues for people living with diabetes on a pump. We will look at: pumps
More informationApplying the Goldilocks Principle to Clinical Decision Support. Carla J Maslakowski M.S, M.Ed, RPh
Applying the Goldilocks Principle to Clinical Decision Support Carla J Maslakowski M.S, M.Ed, RPh Conflict of Interest Disclosure Carla J Maslakowski, M.S., M.Ed, RPh has no real or apparent conflicts
More informationA Virtual Glucose Homeostasis Model for Verification, Simulation and Clinical Trials
A Virtual Glucose Homeostasis Model for Verification, Simulation and Clinical Trials Neeraj Kumar Singh INPT-ENSEEIHT/IRIT University of Toulouse, France September 14, 2016 Neeraj Kumar Singh A Perspective
More informationReducing the risk of patient harm: A focus on opioids
Reducing the risk of patient harm: A focus on opioids New York State Partnership for Patients (NYSPFP) Initiative Regional Educational Session November 2013 1 Disclosure Matthew Fricker, Matthew Grissinger,
More informationDiabetes Medical Management Plan (DMMP)
Diabetes Medical Management Plan (DMMP) This plan should be completed by the student s personal diabetes health care team, including the parents/guardian. It should be reviewed with relevant school staff
More informationPeripherally Inserted Central Catheter (PICC) Booklet
Aintree University Hospital FT PICC Booklet: a real world example This local booklet is an example used in the NICE medical technology guidance adoption support resource for SecurAcath for securing percutaneous
More informationCODING SHEETS CHRONIC INTRACTABLE PAIN MANAGEMENT. Effective January 1, 2009 CODMAN 3000 NEUROMODULATION AND ONCOLOGY REIMBURSEMENT HOTLINE
CODING SHEETS CHRONIC INTRACTABLE PAIN MANAGEMENT Effective January 1, 2009 CODMAN 3000 NEUROMODULATION AND ONCOLOGY REIMBURSEMENT HOTLINE Phone: 800-609-1108 Email: codmanpump@aol.com Fax: 303-703-1572
More informationPurpose: The goal of epidural anesthesia is to reduce or eliminate pain in the laboring patient.
Alaska Native Medical Center: Mother Baby Unit Subject: Epidural Anesthesia/PCEA in Laboring Patients Guideline: Epidural Anesthesia in Laboring Patients REVISION DATE: March 2013 REPLACES: L&D Epidural
More informationAUTOLOGS TM ATLAS ON DEMAND DATA WITH EVERY PATIENT VISIT
AUTOLOGS TM ATLAS ON DEMAND DATA WITH EVERY PATIENT VISIT Introduction The Autologs Atlas will guide your introduction to our new Autologs service and the information recorded by the HeartWare HVAD TM
More informationPharmaceutical risk management strategies for parenteral nutrition. J. Eastwood (UK)
ESPEN Congress Leipzig 2013 Pharmaceutical Session Pharmaceutical risk management strategies for parenteral nutrition J. Eastwood (UK) Pharmaceutical risk management strategies for parenteral nutrition
More informationTHERAPY Baclofen Pump Program at Boston Children s Hospital
BACLOFEN PUMP THERAPY Baclofen Pump Program at Boston Children s Hospital PAGER: 617-355-6369 and ask to page #7867 (PUMP) 1 Contents What is spasticity?... 3 What is baclofen?... 3 The evaluation for
More informationHigh-Alert Medications: A Look at the Safe Use of Narcotics. Allen Vaida, BSc, PharmD Institute for Safe Medication Practices (ISMP)
High-Alert Medications: A Look at the Safe Use of Narcotics Allen Vaida, BSc, PharmD Institute for Safe Medication Practices (ISMP) Risk Identification in Healthcare The detection of a potential or actual
More informationDate of birth: Type 2 Other: Parent/guardian 1: Address: Telephone: Home: Work: Cell: address: Camper physician / health care provider:
Day & Evening Camp 2018 Specialized Health Care Diabetes Medical Management Plan Must be completed if your camper has diabetes. Parent/guardian and physician signature required. **We will also accept copies
More informationVICTORIA INDEPENDENT SCHOOL DISTRICT Diabetes Medical Management Plan
VICTORIA INDEPENDENT SCHOOL DISTRICT Diabetes Medical Management Plan This plan should be completed by the student s personal health care team and parents/guardian. Student s Name: of Birth: of Diabetes
More informationVirginia Diabetes Medical Management Plan (DMMP)
Virginia Diabetes Medical Management Plan (DMMP) Adapted from the National Diabetes Education Program DMMP (2016) This plan should be completed by the student s personal diabetes health care team, including
More informationHomeroom Teacher: Mother/Guardian: Address: Telephone: Home Work. Address: Father/Guardian: Address: Telephone: Home Work Cell: Address:
Community Unit School District No. 1 Diabetes Care Plan 6:120-AP4, E1 This plan should be completed by the student s personal diabetes health care team, including the parents/guardian. It should be reviewed
More informationCharacterization of a novel detector using ROC. Elizabeth McKenzie Boehnke Cedars-Sinai Medical Center UCLA Medical Center AAPM Annual Meeting 2017
Characterization of a novel detector using ROC Elizabeth McKenzie Boehnke Cedars-Sinai Medical Center UCLA Medical Center AAPM Annual Meeting 2017 New Ideas Investigation Clinical Practice 2 Investigating
More informationFACULTY OF PAIN MEDICINE
PM4 (2005) FACULTY OF PAIN MEDICINE AUSTRALIAN AND NEW ZEALAND COLLEGE OF ANAESTHETISTS ABN 82 055 042 852 GUIDELINES FOR PATIENT ASSESSMENT AND IMPLANTATION OF INTRATHECAL CATHETERS, PORTS AND PUMPS FOR
More informationChecklist/Action Plan for the Management of High-Alert Medications
... Attachment 1.G Checklist/Action Plan for the Management of High-Alert Medications (adapted from High-Alert Medications: Safeguarding Against Errors by Michael Cohen and Charles Kilo, In: Medication
More informationUW MEDICINE PATIENT EDUCATION. Peritoneal Dialysis. A treatment option for kidney disease. There are 2 types of PD: continuous ambulatory
UW MEDICINE PATIENT EDUCATION Peritoneal Dialysis A treatment option for kidney disease Class Goals 1. Understand the purpose and basic principles of continuous ambulatory peritoneal dialysis (CAPD). 2.
More informationBest practice for screening of insulin pumps
SECURITY Best practice for screening of insulin pumps By Nina Brooks, Head, Security, ACI World As today s security screening professionals work tirelessly to keep the travelling public safe, there is,
More informationDiabetes Medical Management Plan (DMMP) Handout C.1
This plan should be completed by the child s personal diabetes health care team, including the parents/guardian. It should be reviewed with relevant program staff and copies should be kept in a place that
More informationScopus. Cancer Research and Treatment Activity Report
Scopus Cancer Research and Treatment Activity Report Scopus offers researchers an extensive global and interdisciplinary research database of abstracts and citations from over 5,000 international publishers,
More informationBariatric Surgery Post Op Day Version 2 Approved 11/13/2017
Patient Name: Diagnosis: Allergies with reaction type: Bariatric Surgery Post Op Day Version 2 Approved 11/13/2017 Diagnosis Preferred Location/Unit Surgical ICU Code Status: Full Code Activity Ambulate
More informationDiabetes II Insulin pumps; Continuous glucose monitoring system (CGMS) Ernest Asamoah, MD FACE FACP FRCP (Lond)
Diabetes II Insulin pumps; Continuous glucose monitoring system (CGMS) Ernest Asamoah, MD FACE FACP FRCP (Lond) 9501366-011 20110401 Objectives Understand the need for insulin pumps and CGMS in managing
More information2016 Diabetes Management Plan
Early childhood education and care setting 2016 Diabetes Management Plan Insulin pump therapy [to be used in conjunction with Action Plan] Name of child: Date of birth: Name of centre: Age : This plan
More informationMVP PREMIER PLUS SCHEDULE OF BENEFITS Gold 4 MVP Health Plan, Inc. Embedded Deductible Off Exchange
COST-SHARING Deductible Individual Family Prescription Drug Deductible Individual Family Out-of-Pocket Limit Individual Family OFFICE VISITS Primary Care Visits (or Home Visits) Specialist Visits (or Home
More informationChapter 16 IV Flow Rates. Name three reasons why you think a person may need fluid replacement, IV fluids.
Chapter 16 IV Flow Rates Name three reasons why you think a person may need fluid replacement, IV fluids. NPO Dehydration Deliver medication Nutrition Deliver blood products 1 Chapter 16 Intravenous Flow
More informationSTANDARDIZED PROCEDURE REPROGRAMMING AND REFILLING INTRATHECAL BACLOFEN PUMPS and ACCESSING THE CATHETER ACCESS PORT (Adult,Peds)
I. Definition The purpose of this procedure is to allow the Advanced Health Practitioner (AHP) to reprogram and refill intrathecal Baclofen pumps, as well as access the catheter access port for those AHPs
More informationNOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.
TITLE PARENTERAL NUTRITION ADMINISTRATION AND MONITORING SCOPE Provincial: Acute Care APPROVAL AUTHORITY Clinical Operations Executive Committee SPONSOR Pharmacy Services, Nutrition Services, and Health
More informationThe Smart Way to Check Treatment Plans and Charts. Anne W. Greener, Ph.D., FACR American Association Of Medical Dosimetrists June 15, 2016
The Smart Way to Check Treatment Plans and Charts Anne W. Greener, Ph.D., FACR American Association Of Medical Dosimetrists June 15, 2016 Conflicts NONE Professional Affiliations AAPM Liaison to the AAMD
More informationDrivers have GPS. Dialysis Patients have. Making possible personal.
Drivers have GPS Dialysis Patients have with The Amia System with Sharesource Connectivity Platform. For step-by-step navigation of home peritoneal dialysis. Please see indications for use on the back
More informationDiabetes Medical Management Plan (DMMP)
Diabetes Medical Management Plan (DMMP) Page 1 of 7, DMMP This plan should be completed by the student s personal diabetes health care team, including the parents/guardians. It should be reviewed with
More informationDiabetes Medical Management Plan
SCHOOL DISTRICT OF LEE COUNTY HEALTH SERVICES Print Form Date of Plan Diabetes Medical Management Plan This plan should be completed by the student's personal health care team and parents/guardian. It
More informationUsing Recall Data to Assess the 510(k) Process
Using Recall Data to Assess the 510(k) Process Ralph F. Hall Distinguished Professor and Practitioner University of Minnesota Law School July 28, 2010 Acknowledgments 2 Disclosures 3 Agenda I. Research
More informationReport Reference Guide. THERAPY MANAGEMENT SOFTWARE FOR DIABETES CareLink Report Reference Guide 1
Report Reference Guide THERAPY MANAGEMENT SOFTWARE FOR DIABETES CareLink Report Reference Guide 1 How to use this guide Each type of CareLink report and its components are described in the following sections.
More informationOvercoming Opioid-Induced Oversedation: More Than Meets the Eye
Overcoming Opioid-Induced Oversedation: More Than Meets the Eye ANCC National Magnet Conference 2013 Jeannine M. Brant, PhD, APRN, AOCN Lisa Peterson, RN-BC, BSN Health Care, Education and Research www.billingsclinic.com
More information